跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DRIXINE DECONGESTANT NASAL SPRAY oxymetazoline hydrochloride 0.5 mg/mL bottle - TGA Drug Approval Details
Approvals
/
TGA
/
DRIXINE DECONGESTANT NASAL SPRAY oxymetazoline hydrochloride 0.5 mg/mL bottle
Approved
STANDARD
DRIXINE DECONGESTANT NASAL SPRAY oxymetazoline hydrochloride 0.5 mg/mL bottle
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
1c6ccdbd1eea75a4
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
1c6ccdbd1eea75a4
Product Name
DRIXINE DECONGESTANT NASAL SPRAY oxymetazoline hydrochloride 0.5 mg/mL bottle
Artg Id
161596
Artg Name
DRIXINE DECONGESTANT NASAL SPRAY oxymetazoline hydrochloride 0.5 mg/mL bottle
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
2009-05-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
1c6ccdbd1eea75a4
Type
Standard
Back to TGA Approvals